Qualigen Therapeutics - 53 Year Dividend History | QLGN
Historical dividend payout and yield for Qualigen Therapeutics (QLGN) since 1971. The current TTM dividend payout for Qualigen Therapeutics (QLGN) as of November 20, 2024 is $0.00. The current dividend yield for Qualigen Therapeutics as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.001B |
$0.005B |
|
Qualigen Therapeutics Inc. is a biotechnology company. It is focused on developing products for the treatment and testing of cancer and infectious diseases. The company's product pipeline consist AS1411 and Gold Nanoparticle ALAN, RAS-F3 and STARS(TM) blood cleansing system, which are in clinical stage. Qualigen Therapeutics Inc., formerly known as Ritter Pharmaceuticals Inc., is based in CA, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
